コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 trophil-dependent thromboinflammation during myocardial reperfusion injury.
2 uld prevent neutrophil activation and reduce myocardial reperfusion injury.
3 ming may not utilize ADO's potential against myocardial reperfusion injury.
4 ibution of nondiabetic and diabetic blood to myocardial reperfusion injury.
5 elopment for the treatment of hepatitis C or myocardial reperfusion injury.
6 ity resulting in increased cytoprotection in myocardial reperfusion injury.
7 he protective functional phenotype of MIF in myocardial reperfusion injury.
8 for cardioprotective therapies to attenuate myocardial reperfusion injury and decrease infarct size
9 e pathophysiology and clinical expression of myocardial reperfusion injury and discuss the current st
10 ma has been shown to be cardioprotective for myocardial reperfusion injury and ischemia and may play
11 itself induce cardiomyocyte death, known as myocardial reperfusion injury, for which there is still
12 currently under investigation for preventing myocardial reperfusion injury have the potential to impr
13 associated with oxidative stress, including myocardial reperfusion injury, heart transplantation, st
14 l and antithrombotic properties that reduces myocardial reperfusion injury in animal models of myocar
15 itric oxide bioavailability, and ameliorated myocardial reperfusion injury in the setting of severe h
16 dings suggest that the blood contribution to myocardial reperfusion injury is amplified in diabetes.
21 composition were analyzed in mouse models of myocardial reperfusion injury with genetic and pharmacol